| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novo Integrated Sciences, Inc. (NVOS) has 0 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. NVOS is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2022 | Oliva Robert Letterio | Director | Buy | 10,000 | $2.23 | $22,281.00 | +1.6% | |
| Apr 21, 2021 | Oliva Robert Letterio | Director | Buy | 13,000 | $2.12 | $27,560.00 | +6.7% | |
| Feb 23, 2021 | Oliva Robert Letterio | - | Buy | 9,555 | $4.31 | $41,210.05 | +2.5% |